Table 2. Genotype and allele frequency distribution of AdipoQ (rs1501299) polymorphism in women with and without CVD.
*p<0.05 is statistically significant
Genotype/ allele frequency | Total women | Normolipidemic women | Hyperlipidemic women | |||
---|---|---|---|---|---|---|
With CVD n = 265 | Without CVD n = 258 | With CVD n = 99 | Without CVD n = 142 | With CVD n = 166 | Without CVD n = 116 | |
GG | 49.4 | 43.8 | 43.5 | 45.8 | 53.0 | 41.4 |
GT | 30.2 | 53.5 | 32.3 | 51.4 | 29.0 | 56.0 |
TT | 20.4 | 2.7 | 24.2 | 2.8 | 18.0 | 2.6 |
p = 0.001* | p = 0.001* | p = 0.001* | ||||
G | 64.5 | 70.5 | 59.6 | 71.5 | 67.5 | 69.4 |
T | 35.5 | 29.5 | 40.4 | 28.5 | 32.5 | 30.6 |
p = 0.041* OR = 1.31 (1.01–1.70) | p = 0.008* OR = 1.69 (1.15–2.49) | p = 0.695 OR = 1.09 (0.76–1.57) | ||||
GT+TT Dominant model (GT+TT vs GG) | 50.6 56.2 p = 0.228 OR = 0.79 (0.56–1.12) | 56.5 54.2 p = 0.819 OR = 1.09 (0.65–1.84) | 47.0 58.6 p = 0.071 OR = 0.62 (0.38–1.01) | |||
GT+GG Recessive model (TT vs GT+GG) | 79.6 97.3 p = 0.001* OR = 9.17 (4.08–20.59) | 75.8 97.2 p = 0.001* OR = 11.04 (3.69–33.01) | 82.0 97.4 p = 0.001* OR = 8.30 (2.47–27.9) | |||
GG+TT Co-dominant model (GT vs GG+TT) | 69.8 46.5 p = 0.001* OR = 0.37 (0.26–0.53) | 67.7 48.6 p = 0.005* OR = 0.45 (0.26–0.77) | 71.0 44.0 p = 0.001* OR = 0.31 (0.19–0.52)* |